Vivani Medical, Inc.
VANI
$1.22
-$0.025-2.02%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 9.31M | 8.77M | 8.93M | 8.28M | 8.88M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 26.79M | 25.01M | 24.68M | 24.43M | 25.27M |
Operating Income | -26.79M | -25.01M | -24.68M | -24.43M | -25.27M |
Income Before Tax | -25.54M | -23.75M | -23.49M | -23.46M | -24.20M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -25.54 | -23.75 | -23.49 | -23.46 | -24.20 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -25.54M | -23.75M | -23.49M | -23.46M | -24.20M |
EBIT | -26.79M | -25.01M | -24.68M | -24.43M | -25.27M |
EBITDA | -26.38M | -24.60M | -24.28M | -24.03M | -24.90M |
EPS Basic | -0.44 | -0.42 | -0.43 | -0.44 | -0.46 |
Normalized Basic EPS | -0.28 | -0.26 | -0.27 | -0.28 | -0.29 |
EPS Diluted | -0.44 | -0.42 | -0.43 | -0.44 | -0.46 |
Normalized Diluted EPS | -0.28 | -0.26 | -0.27 | -0.28 | -0.29 |
Average Basic Shares Outstanding | 231.15M | 226.93M | 219.89M | 213.50M | 209.09M |
Average Diluted Shares Outstanding | 231.15M | 226.93M | 219.89M | 213.50M | 209.09M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |